Also categorized in PubMed:
Establishment and Characterization of New Orthotopic and Metastatic Neuroblastoma Models.
x hide permanently

Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.

ncbi.nlm.nih.gov

Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.

J Natl Cancer Inst. 2017 Nov 01;109(11):

Authors: Takagi M, Yoshida M, Nemoto Y, Tamaichi H, Tsuchida R, Seki M, Uryu K, Nishii R, Miyamoto S, Saito M, Hanada R, Kaneko H, Miyano S, Kataoka K, Yoshida K, Ohira M, Hayashi Y, Nakagawara A, Ogawa S, Mizutani S, Takita J